作者: Nobuyuki Kobayashi , Shunichiro Shinagawa , Tomoyuki Nagata , Kazuya Shimada , Nobuto Shibata
DOI: 10.1371/JOURNAL.PONE.0168816
关键词:
摘要: In order to conduct early therapeutic interventions for Alzheimer's disease (AD), convenient, diagnosis markers are required. We previously reported that changes in DNA methylation levels were associated with amnestic mild cognitive impairment (aMCI) and AD. As the results suggested COASY SPINT1 gene promoter regions, present study we examined these regions normal controls (NCs, n = 30), aMCI subjects (n 28) AD 30) using methylation-sensitive high resolution melting (MS-HRM) analysis. The indicated two was significantly increased as compared NCs (P < 0.0001, P ANOVA). Further analysis region particular could be a sensitivity, specificity biomarker (COASY: sensitivity 96.6%, 96.7%; SPINT1: 63.8%, 83.3%). CDR Scale Sum of Boxes (CDR-SB), an indicator dementia severity. region, negatively age elevated positive antibodies Herpes simplex virus type 1 (HSV-1). These findings influenced by various factors. conclusion, considered potentially convenient useful aMCI.